Hunein F. Maassab

Affiliations: 
University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Public Health, Immunology, Pathology
Google:
"Hunein Maassab"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Maassab HF, Ackermann WW. (2006) Nucleic acid metabolism of virus-infected HeLa cells. Annals of the New York Academy of Sciences. 81: 29-37
Tekkanat KK, Maassab HF, Cho DS, et al. (2001) IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent Journal of Immunology. 166: 3542-3548
MAASSAB HF, LOH PC, ACKERMANN WW. (2000) Growth characteristics of poliovirus in HeLa cells: nucleic acid metabolism. The Journal of Experimental Medicine. 106: 641-8
Maassab HF, Bryant ML. (1999) The development of live attenuated cold-adapted influenza virus vaccine for humans. Reviews in Medical Virology. 9: 237-44
Herlocher ML, Ewasyshyn M, Sambhara S, et al. (1999) Immunological properties of plaque purified strains of live attenuated respiratory syncytial virus (RSV) for human vaccine. Vaccine. 17: 172-81
Marschall M, Meier-Ewert H, Herrler G, et al. (1997) The cell receptor level is reduced during persistent infection with influenza C virus Archives of Virology. 142: 1155-1164
Herlocher ML, Clavo AC, Maassab HF. (1996) Sequence comparisons of A/AA/6/60 influenza viruses: mutations which may contribute to attenuation. Virus Research. 42: 11-25
Tomoda T, Morita H, Kurashige T, et al. (1995) Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon-γ production and local IgA response Vaccine. 13: 185-190
Keitel WA, Couch RB, Cate TR, et al. (1994) Variability in Infectivity of Cold-Adapted Recombinant Influenza Virus Vaccines in Humans The Journal of Infectious Diseases. 169: 477-477
Keitel WA, Couch RB, Quarles JM, et al. (1993) Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adults. The Journal of Infectious Diseases. 167: 305-11
See more...